SCHEMBL6014101

SCHEMBL6014101

CCCn1c(=O)c(NC(=O)c2n[nH]cc2Cc2cccc(C(F)(F)F)c2)c(N)n(CC)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 5/20 0.40
ADORA1 P30542 4/20 0.40
ADORA3 P0DMS8 4/20 0.40
ADORA2A P29274 4/20 0.40
PLK4 O00444 1/20 0.40
CDK2 P24941 1/20 0.40
IRAK1 P51617 1/20 0.40
RPS6KA3 P51812 1/20 0.40
PLK3 Q9H4B4 1/20 0.40
CSNK1G3 Q9Y6M4 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 4/20 0.38
TP53 P04637 2/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
CTSK P43235 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5054303 0.88 ADORA2B (0.42) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL239675 0.78 ADORA2B (0.46) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL244147 0.77 ADORA2B (0.55) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL5597238 0.71 ADORA3 (0.44) ADORA2BADORA1ADORA3ADORA2ASMN1; SMN2
SCHEMBL1546107 0.70 ADORA2B (0.54) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL3466169 0.67 ADORA2B (0.65) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL1546710 0.67 ADORA2B (0.57) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL1546132 0.66 ADORA2B (0.51) ADORA2BADORA1ADORA3ADORA2APLK4
SCHEMBL28870440 0.66 MPO (0.49)
SCHEMBL8979367 0.65 ADORA2A (0.51) ADORA2BADORA1ADORA3ADORA2APLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685132-A1 A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-08-02 EP disclosed
WO-2005051951-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2005-06-09 WO disclosed